MEQ Protein #3 MEQ Recombinant Enzyme for Genetic Disorders
Amino Acid Sequence: The MEQ Recombinant Enzyme is designed to replace deficient or malfunctioning enzymes in patients with genetic disorders. The sequence is tailored for optimal activity and stability, with specific focus on the catalytic domain responsible for the enzyme’s function. Modifications: The enzyme may be PEGylated to enhance its stability and prolong its circulation time in the bloodstream. Other modifications, such as glycosylation, are considered to improve solubility and reduce immunogenicity, ensuring that the enzyme is more effective in vivo.
Publication Details
- Journal
- Journal of Medical Clinical Case Reports
- Published
- 2025-08-09
- DOI
- https://doi.org/10.47485/2767-5416.1121
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00